

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : DTXCID5040675
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase II/ Phase III
Sponsor : Bionexus Gene Lab
Deal Size : $10.0 million
Deal Type : Collaboration
Bionexus Gene Lab Corp Partners with BirchBioMed Inc.
Details : The collaboration aims to advance the clinical development of Kynurenic Acid for targeting GPR35 in the treatment of organ fibrosis.
Product Name : FS-2
Product Type : Miscellaneous
Upfront Cash : Undisclosed
October 20, 2025
Lead Product(s) : DTXCID5040675
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase II/ Phase III
Sponsor : Bionexus Gene Lab
Deal Size : $10.0 million
Deal Type : Collaboration
